News

Technology News

NeuroMetrix Receives FDA Clearance For SENSUS

Friday, November 30, 2012 5:18:00 AM PDT | VentureDeal
   Waltham, Massachusetts  --  NeuroMetrix (NASDAQ: NURO) said that it has received 510(k) marketing clearance from the US Food and Drug Administration for its pain management device.

Called SENSUS, device uses a disposable electrode to act as an electrical nerve stimulator intended for chronic pain in the lower leg and foot.

The company says it will launch the new device before the end of 2012.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1